61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
EssilorLuxottica SA
Closed
Sector Healthcare
231.6 -0.73
Overview
Share price change
24h
Min
230.7
Max
234.8
Income | 683M |
|---|---|
Sales | 746M 13B |
P/E Sector Avg | 39.595 94.998 |
EPS | 3.81 |
Dividend yield | 1.963 |
Profit margin | 5.135 |
Recommendations | Buy |
|---|---|
12 Months Forecast | -7.29 downside |
Dividend yield Sector Avg | 1.96% 2.40% |
|---|---|
Next Earnings | 12 Feb 2025 |
Market Cap | 5.4B 104B |
|---|---|
Previous open | 232.33 |
Previous close | 231.6 |
News Sentiment
By Acuity
31%
69%
112 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
EssilorLuxottica SA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
EssilorLuxottica SA Forecast
Price Target
By TipRanks
-7.29% downside
12 Months Forecast
Average 216.75 EUR -7.29%
High 250 EUR
Low 195 EUR
Based on 9 Wall Street analysts offering 12 month price targets forEssilorLuxottica SA - Dist in the last 3 months.
Sentiment
By Acuity
112 / 392 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About EssilorLuxottica SA
EssilorLuxottica SA, formerly known as Essilor International Compagnie Generale D Optique SA, is a France-based ophthalmic company. The Company designs, manufactures and markets a range of lenses, frames and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. The Company operates under a number of brands, including Ray-Ban, Oakley and Varilux, among others. The Company operates in Europe, North America, Asia Pacific, the Middle East, Africa and Latin America.
